Calvin H. Knowlton - 01 Aug 2022 Form 4 Insider Report for Tabula Rasa HealthCare, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Aug 2022, 21:49:29 UTC
Prior SEC filing
14 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian W. Adams, by Power of Attorney

Key filing fact

Calvin H. Knowlton filed Form 4 for Tabula Rasa HealthCare, Inc. on 03 Aug 2022.

Key facts

  • This page summarizes Calvin H. Knowlton's Form 4 filing for Tabula Rasa HealthCare, Inc..
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Aug 2022, 21:49.

Change

  • Previous filing in this sequence was filed on 14 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRHC transaction

Common Stock

Award

Transaction value
$0
Shares
+325,000
Change %
+88%
Price
$0.000000
Shares after
695,347
Date
01 Aug 2022
Ownership
Direct
Footnotes
F1
TRHC transaction

Common Stock

Award

Transaction value
$0
Shares
+200,000
Change %
+74%
Price
$0.000000
Shares after
470,496
Date
01 Aug 2022
Ownership
Held by spouse.
Footnotes
F2
TRHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
20,000
Date
01 Aug 2022
Ownership
Held by trust for children.
TRHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
20,000
Date
01 Aug 2022
Ownership
Held by trust for children.
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person received a restricted stock award of 325,000 shares of the Company's common stock on August 1, 2022. Such common stock will vest in four equal annual installments on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026.

Footnote F2

Dr. Orsula Knowlton, the Reporting Person's spouse, received a restricted stock award of 200,000 shares of the Company's common stock on August 1, 2022. Such common stock will vest in four equal annual installments on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .